Efficacy of lower dose of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer resistant to platinum-based therapy

被引：0
|
作者：
Michalaki, V.
Gennatas, S.
Gennatas, C. G.
机构：
[1] Univ Athens, Arete Hosp, Athens, Greece
[2] Univ Athens, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5116
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5116
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer
    Safra, Tamar
    Menczer, Joseph
    Bernstein, Rinat
    Shpigel, Shulem
    Inbar, Moshe J.
    Grisaru, Dan
    Golan, Abraham
    Levy, Tally
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 205 - 210
  • [2] Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy
    Largillier, R.
    Valenza, B.
    Ferrero, J. -M.
    Novo, C.
    Creisson, A.
    Lesbats, G.
    Mari, V.
    Hebert, C.
    Chamorey, E.
    ONCOLOGY, 2007, 73 (3-4) : 177 - 184
  • [3] Weekly topotecan for recurrent platinum resistant ovarian cancer
    Abushahin, Fadi
    Singh, Diljeet K.
    Lurain, John R.
    Grendys, Edward C.
    Rademaker, Alfred W.
    Schink, Julian C.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (01) : 53 - 57
  • [4] Prospective evaluation of weekly topotecan in recurrent platinum-resistant epithelial ovarian cancer
    Le, T.
    Hopkins, L.
    Baines, K. A.
    Rambout, L.
    Fung-Kee-Fung, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (03) : 428 - 431
  • [5] Weekly topotecan as a salvage therapy in heavily pre-treated patients with recurrent platinum-resistant epithelial ovarian cancer
    Marinaccio, M.
    De Marino, E.
    Mele, E.
    Catacchio, R.
    Meo, D.
    Iezzoni, C.
    Conversano, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Topotecan for recurrent cervical cancer after platinum-based therapy
    Abu-Rustum, NR
    Lee, S
    Massad, LS
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (04) : 285 - 288
  • [7] Weekly topotecan in patients with platinum-sensitive and platinum-resistant recurrent ovarian and peritoneal cancers.
    Tummala, M. K.
    Alagarsamy, S.
    Chyou, P.
    McGuire, W. P., III
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Topotecan in platinum-resistant epithelial ovarian cancer
    Karabulut, B
    Sezgin, C
    Terek, MC
    Uslu, R
    Sanli, UA
    Akman, L
    Ozsaran, A
    Dikmen, Y
    Goker, E
    CHEMOTHERAPY, 2005, 51 (06) : 347 - 351
  • [9] Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer
    Vandenput, I.
    Amant, F.
    Neven, P.
    Berteloot, P.
    Leunen, K.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (01) : 83 - 87
  • [10] Weekly topotecan in the treatment of recurrent and persistent epithelial ovarian cancer
    Safra, Tamar
    Inbar, Moshe
    Menczer, Joseph
    Grisaro, Dan
    Glezerman, Marek
    Levy, Tally
    ANNALS OF ONCOLOGY, 2004, 15 : 136 - 136
12345